Trinity Biotech plc announced that Mr. John Gillard, Group Chief Financial Officer, has informed the Board of Directors of the Company of his intention to resign in order assume a senior finance role in an organisation outside the life sciences sector. Mr. Gillard is expected to leave Trinity Biotech in April 2022 and a process to appoint his successor will now commence.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | -0.60% | -2.37% | -23.08% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.08% | 15.62M | |
-3.17% | 8.22B | |
+6.11% | 5.72B | |
+31.98% | 5.67B | |
-10.03% | 4.11B | |
-59.94% | 2.68B | |
+11.23% | 2.68B | |
-5.14% | 2.37B | |
+18.91% | 2.06B | |
-7.56% | 1.8B |
- Stock Market
- Equities
- TRIB Stock
- News Trinity Biotech plc
- Trinity Biotech plc Announces John Gillard, Group Chief Financial Officer Intention to Resign